Haloperidol, Clonidine and Resolution of Delirium in Critically Ill Patients
link.springer.com
Haloperidol and clonidine use in delirious ICU patients may be associated with reduced probability of delirium resolution. This finding, however, merits further investigation given inherent limitations of this observational analysis.
A total of 3614 patients were included (1165 delirious [32%]; 2449 non-delirious [68%]).
Delirium occurred on 4708 (18.9%) of 24,906 days.
The probability of delirium resolution was lower in delirious patients who received haloperidol (OR 0.47, 95% CI 0.39–0.57), clonidine (OR 0.78, 95% CI 0.63–0.97), or both (OR 0.45, 95% CI 0.36–0.56) compared to untreated delirious patients.
This was a cohort study on a mixed ICU, excluding patients with a primary neurological disorder.